Literature DB >> 3621180

Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.

M Nakajima, D R Welch, P N Belloni, G L Nicolson.   

Abstract

A series of rat 13762NF mammary adenocarcinoma cell clones and subclones of various lung metastatic potentials were examined for their abilities to degrade rat lung subendothelial matrix and purified basement membrane type IV collagen. Metastatic potentials were simultaneously determined based on the ability to form "spontaneous" lung metastases after s.c. injection or "experimental" lung metastases after i.v. injection of cells. Microvessel endothelial cells isolated from rat lung were grown in vitro, and the subendothelial matrix containing type IV collagen was metabolically labeled with [3H]proline. When mammary adenocarcinoma cells were placed on the isolated subendothelial matrix, fragmentation and solubilization of [3H]proline-labeled components were observed; highly metastatic 13762NF cells solubilized the matrix at higher rates than did poorly metastatic cells. The 13762NF cells were assayed for type IV collagenolytic activity using [3H]proline-labeled type IV collagen purified from Engelbreth-Holm-Swarm tumor as a substrate. We found excellent correlation between the type IV collagenolytic activities of living cells and their "spontaneous" lung metastatic potentials (r = 0.993). The levels of type IV collagenolytic activity in the conditioned medium depended on the cell culture conditions. In the presence or absence of acid-treated fetal bovine serum, highly metastatic cells secreted higher amounts of type IV collagenolytic enzymes in active and latent forms than did poorly metastatic cells. Incubation of procollagen type IV with medium conditioned by highly metastatic 13762NF cells and treated with trypsin resulted in the production of several large fragments characteristic of type IV collagen. The results suggest that enzymatic degradation of basement membrane type IV collagen is important in lung metastasis of 13762NF mammary adenocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621180

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  85 in total

1.  Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors:  S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Novel biochemical pathways for 5-Fluorouracil in managing experimental hepatocellular carcinoma in rats.

Authors:  Nabil M Abdel-Hamid; Mohamed A Morsy
Journal:  J Membr Biol       Date:  2010-02-23       Impact factor: 1.843

3.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

4.  Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species.

Authors:  S G Shaughnessy; M R Buchanan; S Turple; M Richardson; F W Orr
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors.

Authors:  G L Nicolson; M Nakajima; J L Herrmann; D G Menter; P G Cavanaugh; J S Park; D Marchetti
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.

Authors:  T Abe; T Mori; K Kohno; M Seiki; T Hayakawa; H G Welgus; S Hori; M Kuwano
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

7.  Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.

Authors:  H Fujii; M Nakajima; I Saiki; J Yoneda; I Azuma; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

8.  MT-MMP expression and localisation in human lung and breast cancers.

Authors:  M Polette; B Nawrocki; C Gilles; H Sato; M Seiki; J M Tournier; P Birembaut
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

9.  A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants.

Authors:  A Zielke; R S Bresalier; A E Siperstein; O H Clark; M Rothmund; Q Y Duh
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

10.  Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.

Authors:  H Kobayashi; H Shinohara; H Ohi; M Sugimura; T Terao; M Fujie
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.